Evelyn Partners Group Ltd’s Elevance Health ELV Stock Holding History

Evelyn Partners Group Ltd’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.64K	Buy	+12	New	+$4.45K	﹤0.01%	510

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Evelyn Partners Group Ltd's ELV Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in Elevance Health (ELV) in Q2 2026: 12 shares worth $4.64K. The stake represents ﹤0.01% of the portfolio and ranks #510 among its holdings.

917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Evelyn Partners Group Ltd held 12 shares of Elevance Health worth $4.64K as of Q2 2026.
Elevance Health was a new Evelyn Partners Group Ltd position in Q2 2026.
Elevance Health made up ﹤0.01% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #510 holding.
917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.